Merck (MRK) Tops Q4 EPS by 4c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Merck (MRK) PT Lowered to $67 at Leerink Partners
February 6, 2018 7:14 AM ESTLeerink Partners lowered its price target on Merck (NYSE: MRK) to $67.00 (from $69.00) while maintaining a Market Perform rating.
... MoreMerck (MRK) PT Raised to $68 at Credit Suisse; Sees Multiple Catalysts Ahead
February 5, 2018 7:11 AM ESTCredit Suisse raised its price target on Merck (NYSE: MRK) to $68.00 (from $67.00) while maintaining an Outperform rating.
Analyst Vamil Divan said they continue to see MRK and expect to see further upside as we see the full data for KEYNOTE-189, as well... More
